Atoxic recombinant holotoxins of Clostridium difficile as immunogens

Details for Australian Patent Application No. 2010325992 (hide)

Owner Tufts University

Inventors Feng, Hanping; Wang, Haiying; Tzipori, Saul

Agent Freehills

Pub. Number AU-A-2010325992

PCT Pub. Number WO2011/068953

Priority 61/265,894 02.12.09 US

Filing date 2 December 2010

Wipo publication date 9 June 2011

International Classifications

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/08 (2006.01) Medicinal preparations containing antigens or antibodies - Clostridium, e.g. Clostridium tetani

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/068953 Priority application(s): WO2011/068953

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010325994-Ophthalmic emulsion

2010325987-System and method for analyzing nonstandard facility operations within a data center